IP Library Granted Patent US 11,559,602
Granted Patent B2
US 11,559,602 · App. 16/461,527 · Granted Jan 24, 2023

Sol for tissue perforation closure, ulcer protection, and vascular embolization

Inventors: Toshio Uraoka (Tokyo, JP); Naohisa Yahagi (Tokyo, JP); Shunji Yunoki (Tokyo, JP); Yoshimi Ohyabu (Tokyo, JP); Takefumi Narita (Tokyo, JP)
Assignees: Tokyo Metropolitan Industrial Technology Research Institute; National University Corporation Gunma University
A61L24/102A61K9/0019A61K47/02A61K47/22A61K47/42A61L31/14A61F2310/00365A61K9/06A61L24/104A61L27/24A61L31/04A61L2300/418A61L2400/04A61L2400/06A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,559,602
App. No.
16/461,527
Granted
Jan 24, 2023
Kind
B2
Abstract

The purpose of the present invention is to provide an injectable sol into a body, suited for delivery through a catheter, and usable for tissue perforation closure, ulcer protection, or vascular embolization. Provided are a sol for tissue perforation closure, a sol for ulcer protection, and a sol for vascular embolization, each containing from 0.6 mass % to 3 mass % of a collagen, water, from 200 mM to 330 mM sodium chloride, and a buffer and having a pH from 6.0 to 9.0.

Claims (20)

1. A method of treating a perforation in a tissue, protecting a tissue against ulceration, embolizing vasculature in a tissue, or adhering a tissue with a gel having a modulus of elasticity of 10 kPa to 200 kPa, which comprises forming the gel on or in the tissue via a two-stage cross-linking process by delivering to the tissue a sol comprising from 1.4 mass % to 1.6 mass % of a collagen, water, 252 mM sodium chloride, at least 0.2 mM genipin, and a buffer and having a pH from 6.0 to 9.0, wherein the buffer contains a phosphate and the collagen includes a telopeptide-removed collagen.

2. The method of claim 1 , wherein the tissue has a perforation and the sol is applied thereto.

3. The method of claim 1 , wherein the tissue has an ulcer and the sol is applied thereto.

4. The method of claim 1 , wherein the tissue is protected against ulceration by application of the sol.

5. The method of claim 1 , wherein the vasculature of the tissue is embolized upon delivery of the sol.

6. The method of claim 1 , wherein the sol adheres parts of the tissue together.

7. The method according to claim 1 , wherein the sol comprises from 0.2 mM to 4 mM of genipin.

8. The method according to claim 1 , wherein the sol is locally delivered to the tissue through a catheter.

9. The method according to claim 1 , wherein said sol forms the gel, wherein the gel attaches to the tissue when contacted therewith.

10. The method of claim 1 , wherein the modulus of elasticity is 20 kPa to 100 kPa and the concentration of genipin is 100 mg/L to 1000 mg/L.

11. A method of treating a perforation in a tissue, protecting a tissue against ulceration, embolizing vasculature in a tissue, or adhering a tissue with a gel having a stress-strain profile whereby the amount of stress increases with the amount of strain, which comprises forming the gel on or in the tissue via a two-stage cross-linking process by delivering to the tissue a sol comprising from 1.4 mass % to 1.6 mass % of a collagen, water, 252 mM sodium chloride, at least 0.2 mM genipin, and a buffer and having a pH from 6.0 to 9.0, wherein the buffer contains a phosphate and the collagen includes a telopeptide-removed collagen.

12. The method of claim 11 , wherein the tissue has a perforation and the sol is applied thereto.

13. The method of claim 11 , wherein the tissue has an ulcer and the sol is applied thereto.

14. The method of claim 11 , wherein the tissue is protected against ulceration by application of the sol.

15. The method of claim 11 , wherein the vasculature of the tissue is embolized upon delivery of the sol.

16. The method of claim 11 , wherein the sol adheres parts of the tissue together.

17. The method according to claim 11 , wherein the sol is locally delivered to the tissue through a catheter.

18. The method according to claim 11 , wherein said sol forms the gel, wherein the gel attaches to the tissue when contacted therewith.

19. The method according to claim 11 , wherein said sol has a viscosity from 0.2 Pa·s to 52 Pa·s at 23° C. and a shear rate of 1 s −1 .

20. A method of treating a perforation in a tissue, protecting a tissue against ulceration, embolizing vasculature in a tissue, or adhering a tissue with a gel having a modulus of elasticity of 20 kPa to 100 kPa, which comprises delivering to the tissue a sol comprising from 1.4 mass % to 1.6 mass % of a collagen, water, 252 mM sodium chloride, 100 mg/L to 1000 mg/L genipin, and a buffer and having a pH from 6.0 to 9.0, wherein the buffer contains a phosphate and the collagen includes a telopeptide-removed collagen.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2021
From: URAOKA, TOSHIO
To: NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
Reel/Frame 055082/0519 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2019
From: YUNOKI, SHUNJI; OHYABU, YOSHIMI; NARITA, TAKEFUMI
To: TOKYO METROPOLITAN INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
Reel/Frame 051115/0882 →
SECURITY INTEREST Recorded Nov 26, 2019
From: TOKYO METROPOLITAN INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE; KEIO UNIVERSITY; INDEPENDENT ADMINISTRATIVE AGENCY, NATIONAL HOSPITAL ORGANIZATION
To: URAOKA, TOSHIO
Reel/Frame 051116/0074 →
Priority Claims (1)
JP JP2016-224255 · Nov 17, 2016 · national
Continuity (1)
Related Publication 20190343992A1 · Nov 14, 2019